Base period: date of award - 10/14/2010

Ended Awarded Last action

Contract number
W81K0211F0001
Awardee
Awarding agency
Obligated
$481,063

Award facts

Contract value 100% obligated
$481,063.06 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
Contracting staff
NAICS code
325412 Pharmaceutical Preparation Manufacturing
PSC
6505 Drugs And Biologicals
Set-aside
No set-aside
Competition
Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
Pricing
Firm Fixed Price
Place of performance
Hampton, NJ 08827, USA

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Close Out P00022 · Reagents; MOD to closeout do. -$61,408
Terminate for Convenience P00021 · Nitric oxide inhalation therapy - modification to deobligate unused FY12 and 13 funds. No close out yet due to discrepancies in gfebs for FY14 and 15. -$69,997
Supplemental Agreement for work within scope P00020 · Nitric oxide - decrease quantity on clin 4001 and add new clin -$33,360
Funding Only Action P00019 · Nitric oxide - release FY15 funds $153,534
Other Administrative Action P00018 · Inotherapy nitric oxide - change pay office $0
Exercise an Option P00017 · Exercise option IV: 10/01/2014 - 09/30/2015 -$0
Funding Only Action P00016 · Provide FY14 funds $126,715
Supplemental Agreement for work within scope P00015 · Nitric oxide - increase quantity to clin 2001 $10,000
Exercise an Option P00014 · Exercise option 3: 10/1/2013 - 9/30/2014 $0
Supplemental Agreement for work within scope P00013 · Revise pricing based on 2013 public law 102-585 pricing update and updated FSS contract V797P-5186B. $0
Supplemental Agreement for work within scope P00012 · Realignment of clins. $80,120
Supplemental Agreement for work within scope P00011 $0
Funding Only Action P00010 · Inotherapy nitric oxide for use with impact model 754, biomed MVP-10 and pulmonetic systems LTV1000 ventilator - release FY13 funds for option 2 $127,152
Exercise an Option P00009 · Nitric oxide - exercise option 2: 10/1/2012 - 9/30/2013 $0
Supplemental Agreement for work within scope P00008 · Nitric oxide - updated FSS price -$0
Funding Only Action P00007 · Inotherapy nitric oxide - deob unused funds -$34,783
Supplemental Agreement for work within scope P00006 · Inotherapy nitric oxide - change unit price for options and decr quantity for option i -$16
Funding Only Action P00005 · Nitric oxide - release FY12 funds $120,582
Exercise an Option P00004 · Nitric oxide - exercise option 1: 10/1/2011 - 9/30/2012 $0
Funding Only Action P00003 · Change unit price -$57
Other Administrative Action P00002 $0
Other Administrative Action P00001 · Base period: 11/1/2010 - 9/30/2011 $0
Original award $62,582
Show all 23

Quick answers

Who was awarded contract W81K0211F0001?

W81K0211F0001 was awarded to INO Therapeutics LLC by Medical Command (Department of the Army) on October 29, 2010.

How much is contract W81K0211F0001 worth?

The government has obligated $481,063 on W81K0211F0001.

Is contract W81K0211F0001 an order under another contract?

Yes. W81K0211F0001 is a delivery order under V797P5186B, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).

Was contract W81K0211F0001 competed?

The extent of competition for W81K0211F0001 was full and open competition. The government received 1 offer.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award
Try for free Login